Saturday, September 23, 2023
Saturday, September 23, 2023

Recent Hologic Acquisition Bolder Surgical Included on Fast Company’s Annual List of World’s Most Innovative Companies

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that recently acquired Bolder Surgical was included on Fast Company’s annual list of the World’s Most Innovative Companies. Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing and dissection tools for surgical gynecologists in both laparoscopic and open procedures was acquired by Hologic in November 2021.

Hologic notes Bolder ranked fifth on the list of Most Innovative Medical Device Companies, a sector highlighting companies that are creatively using technology to improve patient care. The full list of Most Innovative Companies consisted of 528 companies chosen by a team of editors and reporters for Fast Company from thousands of applicants across the globe.

“We’re thrilled that Bolder — the newest member of our Surgical business — has captured a spot on Fast Company’s prestigious list of the most innovative companies making an impact around the globe,” said Essex Mitchell, Hologic’s Division President, Surgical. “The CoolSeal devices have already proven to be an important addition to our growing Surgical portfolio, and we’re looking forward to seeing how we can continue to improve efficiency for surgeons and hospitals, while helping to improve outcomes for patients, through these innovative products.”

Bolder was recognized for its innovation in designing surgical devices, in particular the CoolSeal® devices, which allows for dissection, vessel sealing and dividing all in one tool. The ability to use a combination device improves surgical efficiency by reducing the need for instrument exchanges. In addition, Bolder’s CoolSeal® Mini 3 mm vessel sealer and the JustRight® 5 mm stapler are designed for small surgical spaces such as in pediatric cases, which can help reduce the need for larger, overpowered instruments.

Hologic’s surgical product line also includes the NovaSure® endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure® tissue removal devices for the removal of intrauterine fibroids and polyps, the Acessa® laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent® fluid management system for streamlining hysteroscopic procedures.

According to Fast Company, the Most Innovative Companies list “has been the definitive source for recognizing the organizations that are transforming industries and shaping society” since it began in 2008.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy